High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital.
Patricia Cornejo-JuárezMiguel Angel CevallosSemiramis Castro-JaimesSantiago Castillo-RamírezConsuelo Velázquez-AcostaDavid Martínez-OlivaAngeles Pérez-OsegueraFrida Rivera-BuendíaPatricia Volkow-FernándezPublished in: PloS one (2020)
There were 106 strains of A. baumannii isolated during the study period. Sixty-six (62.3%) were considered as infection and 40 (37.7%) as colonization. The index case, identified by molecular epidemiology, was a patient with a drain transferred from a hospital outside Mexico City. Ninety-eight additional cases had the same MultiLocus Sequence Typing (MLST) 758, of which 94 also had the same plasmid profile, two had an extra plasmid, and two had a different plasmid. The remaining seven isolates belonged to different MLSTs. Fifty-three patients (50%) died within 30 days of A. baumanniii isolation: 28 (20%) in colonized and 45 (68.2%) in those classified as infection (p<0.001). In multivariate regression analysis, clinical infection and patients with hematologic neoplasm, predicted 30-day mortality. The molecular epidemiology of this outbreak showed the threat posed by the introduction of MDR strains from other institutions in a hospital of immunosuppressed patients and highlights the importance of adhering to preventive measures, including contact isolation, when admitting patients with draining wounds who have been hospitalized in other institutions.
Keyphrases
- multidrug resistant
- acinetobacter baumannii
- escherichia coli
- end stage renal disease
- drug resistant
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- crispr cas
- pseudomonas aeruginosa
- cardiovascular events
- case report
- acute care
- peritoneal dialysis
- adverse drug
- cardiovascular disease
- cystic fibrosis
- robot assisted
- amino acid
- drug induced